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Osteoporosis in the rheumatoid hand -
the effects of treatment with
o-penicillamine and oral gold salts
D. SCHORN
Summary~
Osteoporosis is a common and important feature of
rheumatoid disease which can be further influenced
by the treatment admiflistered. o-penicillamine. a
lathyritic agent. can also theoretically hasten the
osteoporotic process through its effect on collagen
metabolism. In the present study the effects of the
long-term second-line drugs o-penicillamine and
oral gold (Auranofin) on bone density are pre-
sented. All the patients studied lost bone mineral
over the 3-year period, but continuous D-penicilla-
mine therapy for 1 year reversed this t"rend. Oral
gold did not have the same effect.
Measurements of bone density are an accurate
indirect measurement of hand function, and there is
a good correlation between hand function and the
progress of osteoporosis. It is therefore suggested
that treatment with o-penicillamine reverses the
tendency to lose bone mineral improving synovitis.
thus leading to improved hand function.
S Air Med J 1983; 63: 121-123.
Osteoporosis is a common and important complication of rheu-
matoid disease and can be peri-articular or generalized. 1,2 Va-
rious techniques have been used to study osteoporosis in rheu-
matoid disease,3 and controlled studies have shown that bone
mass is reduced in the femur and clavicle, suggesting that osteo-
porosis is not purely a localized condition caused by joint des-
truction. It has been difficult to show a relationship between the
degree of osteoporosis and the activity of the rheumatoid pro-
cess. It is, however, clear that the degree of osteoporosis does
depend on the duration of the rheumatoid disease.3 It is not
certain to what extent the different possible causes ofosteoporo-
sis are involved in rheumatoid disease, but immobilization, die-
tary deficiency, malabsorption and possibly liver disease have
been implicated. It has been suggested that patients with rheu-
matoid disease who receive corticosteroids are more likely to
develop osteoporosis than patients receiving them for bronchial
asthma or Cushing's syndrome; this may be because the joint
disease leads to a mobility problem.
Radiological evaluation of osteoporosis is difficult, and other
methods of evaluating bone status have been developed. These
include quantified radiological and photon absorption methods.
X-ray densitometry h?s largely been replaced by X-ray mor-
phometry in which measurements are made directly from the
radiographs. In the present study X-ray morphometry, i.e. mea-
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surement of the metacarpal index of Barnen and Nordin,4 has
been used to determine the effect of the long-term agent D-
penicillamine or oral gold salts (Auranofin) on the progression of
osteoporosis in the metacarpal bones.
Patients and methods
A metacarpal index of osteoporosis was determined using stan-
dard posterior-anterior radiography of the hands. The latter
were read blind and in a randomized order in an effort to avoid
bias. The outside (D) and inside (d) diameters of the second
metacarpal bone of the right hand were measured at their mid-
point with a Vernier caliper (accurate to 0,01 mm) (Fig. I). An area
index (AI) was calculated from the formula D2 - d2, which gives
an assessment of the cortical bone diameter (rr/2 D2 - d2).
Exton-Smith er af. 5 have shown that this index correlates well
with the ash weight of bone (r = 0,85). All the patients studied
had classic or definite rheumatoid arthritis (RA) of at least I
year's duration. Only patients in functional and anatomical
classes 2 and 3 were studied. All patients who had previously
undergone upper limb surgery were excluded from the study.
Hand function was judged according to the patient's ability to
perform daily activities, e.g. occupation, housework and per-
sonal care.
Control group. The control group consisted of 113 patients
(25 males and 88 females) with RA. The mean ages were 46,4
years for the males and 50,6 years for the females, and the mean
duration of disease was 6,1 years. Ten male and 26 female
patients had each taken an average of6 mg prednisolone per day
for at least 2 years before the first radiograph was taken. Radio-
graphy was repeated after a mean period of3 years. No patient in
this group had ever received antimalarial drugs, gold, penicilla-
mine or immunosuppressives.
o-penicillamine group. All the patients in both the penicil-
lamine and gold salts groups had had active rheumatoid disease
that was not responsive to the usual non-steroidal anti-
inflammatory drugs for at least 9 months. This was characterized
by persistent joint swelling, pain and stiffness and an increased
erythrocyte sedimentation rate. Radiographs of 42 patients'
hands were taken immediately before and after I year of conti-
nuous treatment with D-penicillamine (mean dose 750 mg/d).
There were 13 male and 29 female patients, with a mean age of
49,8 years and mean duration of disease of4,9 years (range I - II
years). Twenty-one patients (7 males and 14 females) had also
had radiographs taken of the hands some 3 years before D-
penicillamine treatment was started.
Oral gold group. Seventeen patients (I male and 16 females)
were studied. The mean age was 53,7 years and the mean dura-
tion of disease 4,8 years (range I - 12 years). Radiographs were
taken before oral gold treatment was started and again after I
year ofcontinuous treatment with 6 mg/d. No patient was taking
corticosteroid drugs.
Hand function in the D-penicillamine and oral gold groups
before treatment was started was similar, and was judged as
previously described by the effects of the arthritis on daily living.





Fig. 1. Measurements used for calculation of the metacarpal index.
Results
Standardization
A series of 100 radiographs of the hands was used to determine
the intra-observer error for the measurements. The measure-
ments (D and d) of 100 metacarpal bones were taken and the
procedure was repeated 3 days later. The difference between the
readings (mean 2,4%) is quoted as the intra-observer error. This
was not statistically significant (P> 0,05).
Progression of bone loss
Non-corticosteroid-treated patients. The Als for the
right second metacarpal bone calculated from radiographs taken
a mean of3 years apart were compared. Patients were subdivided
into groups according to the duration of rheumatoid disease
when the ftrst radiograph was taken (0 - 5 years, 6 - 10 years, 11
-16 years, and> 16 years). The changes in the Als for the
different groups are shown in Table I. There was a progressive
reduction in AI despite the fact that in all four groups the mean
age had been similar when the ftrst radiograph was taken. The
difference between the AI for the 0 - 5-year group (61,7) and for
the 6 - 10-year group (53,5) was statistically significant (P <
0,0005), as was the difference between the 6 - 10-year group and
the 11 - l5-year group; however, the latter was smaller (P <
0,025). There was no difference between the 11 - 15-year and >
l6-year groups. The mean reduction in AI became progressively
smaller with a longer duration of disease. This is shown both by
the absolute changes in Al and by the statistical analysis, where
the P values became progressively greater. There was a statisti-
cally signiftcant reduction in the Als' of all groups of patients
during the observation period.
Corticosteroid-treated patients. Again the two hand radio-
graphs were taken a mean of 3 years apart; all patients had been
taking corticosteroids before the ftrst radiograph was taken and
had continued to use them during the observation period. Like
the non-corticosteroid-treated patients they were further subdi-
vided into groups according to the duration of the disease, and
the results are shown in Table 11. The groups are small in
comparison with the non-eorticosteroid-treated groups, but
other than in the>l6-year group the initial AI was not signifi-
cantly lower in those patients who had had the disease for longer
periods. Again there was a progressive reduction in AI over the
3-year observation period in all four groups. It was not possible
to perform a separate statistical analysis comparing bone loss in
male and female patients in the different groups because of the
small numbers of males, but the males also showed a progressive
reduction in AI over the observation period in all the groups.
Effects ofD-penicillamine. Twenty-one patients had radio-
graphs taken a mean of 36 months before the start of D-
penicillamine treatment and again after 1 year of continuous
therapy (mean dose 750 mg/d). During this time the patients
also received standard anti-inflammatory drugs when necessary.
No patient had undergone hand, wrist or elbow surgery. There
was a decrease in AI in the 3-year period before treatment was
started from a mean of 62,2 (± 12,6) to 58,2 (± 15,4) (P<0,025)
(paired ctest). After a mean of 1 year of D-penicillamine therapy
there was'an increase in mean AI from 58,2 (± 15,4) to 63,5 (±
15,4) (P < 0,01) (paired ctest). Follow-up radiographs were also
TABLE I. MEAN AI (± SD) IN FOUR GROUPS OF NON-CORTICOSTEROID-TREATED PATIENTS
Duration of disease (yrs)
Initial AI







53,5 (± 10,9) 48 (± 10,8)






TABLE 11. MEAN AI (± SD) IN FOUR GROUPS OF CORTICOSTEROID-TREATED PATIENTS
Duration of disease (yrs)
Initial AI







60,3 (± 20,5) 61,3 (± 6,5)











Fig. 1. Measurements used for calculation of the metacarpal index.
Results
Standardization
A series of 100 radiographs of the hands was used to determine
the intra-observer error for the measurements. The measure-
ments (D and d) of 100 metacarpal bones were taken and the
procedure was repeated 3 days later. The difference between the
readings (mean 2,4%) is quoted as the intra-observer error. This
was not statistically significant (P > 0,05).
Progression of bone loss
Non-corticosteroid-treated patients. The Als for the
right second metacarpal bone calculated from radiographs taken
a mean of 3 years apart were compared. Patients were subdivided
into groups according to the duration of rheumatoid disease
when the fIrst radiograph was taken (0 - 5 years, 6 - 10 years, 11
-16 years, and> 16 years). The changes in the Als for the
different groups are shown in Table I. There was a progressive
reduction in AI despite the fact that in all four groups the mean
age had been similar when the fIrst radiograph was taken. The
difference between the AI for the 0 - 5-year group (61,7) and for
the 6 - lO-year group (53,5) was statistically significant (P <
0,0005), as was the difference between the 6 - 1O-year group and
the 11 - 15-year group; however, the laner was smaller (P <
0,025). There was no difference between the 11 - 15-year and >
16-year groups. The mean reduction in AI became progressively
smaller with a longer duration of disease. This is shown both by
the absolute changes in A1 and by the statistical analysis, where
the P values became progressively greater. There was a statisti-
cally significant reduction in the Als' of all groups of patients
during the observation period.
Corticosteroid-treated patients. Again the two hand radio-
graphs were taken a mean of 3 years apart; all patients had been
taking corticosteroids before the fIrst radiograph was taken and
had continued to use them during the observation period. Like
the non-corticosteroid-treated patients they were further subdi-
vided into groups according to the duration of the disease, and
the results are shown in Table 11. The groups are small in
comparison with the non-eorticosteroid-treated groups, but
other than in the>16-year group the initial AI was not signifi-
cantly lower in those patients who had had the disease for longer
periods. Again there was a progressive reduction in AI over the
3-year observation period in all four groups. It was not possible
to perform a separate statistical analysis comparing bone loss in
male and female patients in the different groups because of the
small numbers of males, but the males also showed a progressive
reduction in AI over the observation period in all the groups.
Effects ofD-penicillamine. Twenty-one patients had radio-
graphs taken a mean of 36 months before the start of D-
penicillamine treatment and again after I year of continuous
therapy (mean dose 750 mg/d). During this time the patients
also received standard anti-inflammatory drugs when necessary.
No patient had undergone hand, wrist or elbow surgery. There
was a decrease in AI in the 3-year period before treatment was
started from a mean of 62,2 (± 12,6) to 58,2 (± 15,4) (P<0,025)
(paired r test). After a mean of 1 year of D-penicillarnine therapy
there was'an increase in mean AI from 58,2 (± 15,4) to 63,5 (±
15,4) (P < 0,01) (paired r test). Follow-up radiographs were also
TABLE I. MEAN AI (± SD) IN FOUR GROUPS OF NON-CORTICOSTEROID-TREATED PATIENTS
Duration of disease (yrs)
Initial AI







53,5 (± 10,9) 48 (± 10,8)






TABLE 11. MEAN AI (± SD) IN FOUR GROUPS OF CORTICOSTEROID-TREATED PATIENTS
Duration of disease (yrs)
Initial AI







60,3 (± 20,5) 61,3 (± 6,5)
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